Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Amyloid-beta (Aβ) plays a central role in the pathogenesis of Alzheimer's disease (AD), and it is a major therapeutic target for AD. It is proposed that removal of Aβ in blood can facilitate Aβ clearance from the brain, representing a promising therapeutic approach for AD. However, the efficacy and mechanisms for Aβ clearance by peripheral organs and tissues remain largely unknown. In the present study, 47 chronic kidney disease (CKD) patients (16 newly diagnosed patients who had never been dialyzed and 31 patients who were receiving dialysis) and 43 normal controls (NC) were enrolled. We found that serum Aβ levels were significantly higher in CKD patients than NC. CKD patients who were receiving dialysis had lower serum Aβ levels than patients without receiving dialysis, being comparable to NC. Furthermore, serum Aβ levels were correlated with renal functions reflected by estimated glomerular filtration rate (eGFR) and residual GFR (rGFR). Our study suggests that kidney is involved in peripheral clearance of Aβ, and dialysis might be a potential therapeutic approach of Aβ removal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with CKD and animals undergoing unilateral nephrectomy exhibit elevated levels of circulating and cerebral Aβ, along with impaired cognition.254–256”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [254]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · cited 1×
“Estimated glomerular filtration rate (eGFR), representing general GFR was calculated using the CKD-EPI equation based on serum creatinine levels [9].”
MethodPrevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · cited 1×
“Chronic kidney disease (CKD), defined by a gradual loss of renal function, and Alzheimer’s disease (AD) are both common diseases in the elderly [1, 2].”
BackgroundCD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570 · cited 1×
“A recent study found that a single nucleotide polymorphism (SNP) of CD33, which reduces the capacity of Aβ endocytosis in circulating monocytes, increases the risk of AD [16].”
BackgroundSehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., Khanna, P., Jain, S. C., Thakur, S. S., & Ravindranath, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112209109 · Cited by 390
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367 · cited 2×
“The medical history was collected as per our previous study from medical records and a formal questionnaire including current medications [8].”
MethodResultSelf-citationContribution of Alzheimer disease to mortality in the United States
James, B. D., Leurgans, S. E., Hebert, L. E., Scherr, P. A., Yaffe, K., & Bennett, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000240 · Cited by 361
Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study
Helmer, C., Stengel, B., Metzger, M., Froissart, M., Massy, Z.-A., Tzourio, C., Berr, C., & Dartigues, J.-F. (2011) · Neurology · doi:10.1212/wnl.0b013e31823b4765 · Cited by 206 · cited 1×
“Indeed, CKD increases risks for developing dementia including AD [15].”
BackgroundClearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
Wang, Y.-J., Zhou, H.-D., & Zhou, X.-F. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.004 · Cited by 205 · cited 1×
“Insufficient clearance of brain Aβ contributes to the initiation and progression of sporadic AD [11].”
BackgroundSelf-citationLemere, C. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00044-5 · Cited by 139
(2012) · doi:10.1038/nrneurol.2012.118 · Cited by 122 · cited 3×
“Removal of brain Aβ via this peripheral approach can avoid adverse effects related to brain entry of Aβ removing agents [6].”
BackgroundSelf-citation
Cited by
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Self-citationXiang, Y., Bu, X.-L., Liu, Y.-H., Zhu, C., Shen, L.-L., Jiao, S.-S., Zhu, X.-Y., Giunta, B., Tan, J., Song, W.-H., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1477-1 · Cited by 277
“We also found that the levels of Aβ in blood are higher in patients with renal failure than normal controls [26].”
BackgroundSelf-citationCheng, Y., Tian, D.-Y., & Wang, Y.-J. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00195-1 · Cited by 190
“In addition, the serum Aβ levels and brain Aβ depositions were found to be significantly increased in chronic kidney disease (CKD) patients [93, 94], indicating that the reduced kidneymediated Aβ clearance may contribute to AD pathology”
Self-citationThe Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S., & Stellos, K. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.033 · Cited by 188
“Hemodialysis Cross-sectional study of 47 patients with CKD Plasma levels of Ab1-40 and -42 are reduced (117)”
BackgroundAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citation
Metadata
- Authors
- Liu, Y.-H., Xiang, Y., Wang, Y.-R., Jiao, S.-S., Wang, Q.-H., Bu, X.-L., Zhu, C., Yao, X.-Q., Giunta, B., Tan, J., Zhou, H.-D., & Wang, Y.-J.
- Affiliations
- Army Medical University (CN)
- University of South Florida (US)
- Corresponding author
- Wang, Yan-Jiang
- Venue
- Molecular Neurobiology
- Published
- 2014-08-14
- Volume
- 52
- Issue
- 1
- Pages
- 115-119
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2033225660
- Cited by
- 83
- References
- 20
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 10 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 3
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- amyloid-beta, chronic kidney disease, dialysis, renal clearance, Alzheimer's disease, estimated glomerular filtration rate, residual glomerular filtration rate, kidney
- MeSH terms
- Demography, Female, Humans, Kidney, Male, Middle Aged, Amyloid beta-Peptides, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance. https://app.cochat.ai/papers/10.1007/s12035-014-8854-y
- The paper
- Liu, Y.-H., Xiang, Y., Wang, Y.-R., Jiao, S.-S., Wang, Q.-H., Bu, X.-L., Zhu, C., Yao, X.-Q., Giunta, B., Tan, J., Zhou, H.-D., & Wang, Y.-J. (2015). Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance. Molecular Neurobiology. https://doi.org/10.1007/s12035-014-8854-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.